|Bid||61.23 x 1100|
|Ask||61.50 x 1000|
|Day's Range||61.13 - 62.23|
|52 Week Range||42.14 - 66.41|
|Beta (3Y Monthly)||1.38|
|PE Ratio (TTM)||52.81|
|Earnings Date||Oct 29, 2019 - Nov 4, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||67.75|
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
PLAINSBORO, N.J., Aug. 21, 2019 -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following.
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Integra LifeSciences Holdings Corporation (IART) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
PLAINSBORO, N.J., July 29, 2019 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that it has acquired.
Integra (IART) delivered earnings and revenue surprises of 12.31% and 2.70%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, NY / ACCESSWIRE / July 24, 2019 / Integra LifeSciences Holdings Corp. (NASDAQ: IART ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 24, 2019 ...
Reported revenues increased 4.8% to $383.6 million; organic revenues increased 6.6% GAAP and adjusted earnings per diluted share were $0.34 and $0.73, respectively.
Today we'll evaluate Integra LifeSciences Holdings Corporation (NASDAQ:IART) to determine whether it could have...
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PLAINSBORO, N.J., July 10, 2019 -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2019.
Integra LifeSciences (IART) expects its partnership with Tissue Analytics to be perfectly strategic as the latter's software solutions automatically derive high quality data from clinical pictures.
BALTIMORE , July 8, 2019 /PRNewswire/ -- Integra LifeSciences, a leading global medical technology company, is pleased to announce a pioneering partnership with Tissue Analytics , an AI-powered software ...
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To keep it practical, we'll...
Integra LifeSciences Holdings Corporation (IART), a leading global medical technology company, today announced the promotion of Glenn Coleman to the newly-created role of chief operating officer (COO) and appointed Carrie Anderson as chief financial officer (CFO), effective June 24, 2019. “Having doubled the size of our business over the past several years and nearly completing the transformational Codman acquisition integration, we have reached a critical inflection in Integra’s history,” said Peter Arduini, president & chief executive officer, Integra LifeSciences. “Looking at the opportunities ahead, the creation of the COO role will provide the oversight we need to accelerate our future growth. The move will also allow me to focus greater attention on our long-term strategic direction and spend more time with our customers. I’m also excited to welcome Carrie to Integra.
Today we will run through one way of estimating the intrinsic value of Integra LifeSciences Holdings Corporation...
In this article we are going to estimate the intrinsic value of Integra LifeSciences Holdings Corporation...
Investors are always looking for growth in small-cap stocks like Integra LifeSciences Holdings Corporation...